Please login to the form below

Not currently logged in
Email:
Password:

Huntsworth buys Giant Creative Strategy

New acquisition will expand Huntsworth’s reach

HuntsworthHuntsworth has acquired San-Francisco-based agency Giant Creative Strategy for an initial cash consideration of $72.2m, however that figure could be raised to as much as $97.2m.

The amount, which will be funded from existing debt facilities, is entirely dependent on Giant’s earnings between the years of 2019 and 2021. Last year however, the group reported revenue of around $32m.

Following the transaction, Giant’s founders, chief executive Steven Gold and president Adam Gelling will remain with the multichannel agency along with its 150 staff members.

Giant’s future will see its combined with Huntsworth’s existing marketing agency Evoke Health, a New York-based health and wellness agency.

Reid Connolly, chief executive of Evoke Group, said: “Clients continue to look for opportunities to work with fewer agency partners on larger remits - consolidating business to those with proven and differentiated credentials and expertise in all key brand areas.

“Evoke has built our offering to accommodate this market shift and the addition of Giant adds an even more robust and differentiated HCP marketing offering to the group, as well as expanded geographic reach.”

Giant, which has a roster of pharmaceutical, biotech and medical device clients will boost Evoke’s capabilities in data and analytics while tapping into Evoke’s marketing power.

Paul Taaffe, Huntsworth chief executive, said: “Giant is a strong addition to the Group, bringing scale in healthcare professional marketing.

“This expansion of Huntsworth makes it an even more compelling alternative to the large holding company networks.”

Huntsworth currently operates from 46 main hubs across 19 countries. The group has divisions in the fields of communications, medical and marketing.

Article by
Gemma Jones

18th July 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
M3 (EU)

M3 is the world’s largest network of verified doctors with over 6 million members across key markets; our closed and...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...